Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal timing of rapid-acting insulin aspart administration before meal
2008-005598-36Phase 4Completed
- Sponsor
- Amsterdam UMC
- Start
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of insulin aspart in diabetes mellitus type 1 (T1D) (3 arms), sponsored by Amsterdam UMC. Primary endpoint: Postprandial plasma glucose excursion (AUC 0–5h). Started Nov 2008; status: completed.
02
Drugs
insulin aspart
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2008-005598-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005598-36.